4.6 Editorial Material

Is the scavenger receptor MARCO a new immune checkpoint?

Journal

ONCOIMMUNOLOGY
Volume 3, Issue 10, Pages -

Publisher

LANDES BIOSCIENCE
DOI: 10.4161/21624011.2014.955709

Keywords

cancer immunotherapy; dendritic cell activation; immune checkpoint inhibitor; scavenger receptor MARCO; Toll-like receptor

Ask authors/readers for more resources

Whereas macrophages use the scavenger receptor MARCO primarily in antimicrobial immunity by interacting with both exogenous and endogenous environments, in dendritic cells (DCs) MARCO is believed to pleiotropically link innate to adaptive immunity. MARCO exerts a significant modulatory effect on TLR-induced DC activation, thus offering novel avenues in cancer immunotherapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available